Kalvista pharmaceuticals reports inducement grants under nasdaq listing rule 5635(c)(4)

Cambridge, mass. & salisbury, england--(business wire)--kalvista pharmaceuticals, inc. (nasdaq: kalv), today announced that the compensation committee of kalvista's board of directors granted six newly-hired employees inducement options to purchase an aggregate of 31,000 shares of kalvista common stock on october 1, 2024 as inducements material to each employee entering into employment with kalvista. the options were granted in accordance with nasdaq listing rule 5635(c)(4). the options have an.
NDAQ Ratings Summary
NDAQ Quant Ranking